NFL Biosciences Statistics

Total Valuation

NFL Biosciences has a market cap or net worth of EUR 4.94 million. The enterprise value is 3.32 million.

Market Cap	4.94M
Enterprise Value	3.32M

Important Dates

The last earnings date was Thursday, October 22, 2026.

Earnings Date	Oct 22, 2026
Ex-Dividend Date	n/a

Share Statistics

NFL Biosciences has 12.67 million shares outstanding.

Current Share Class	12.67M
Shares Outstanding	12.67M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	14.21%
Owned by Institutions (%)	0.19%
Float	10.87M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	1,599.64
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

Current Ratio	n/a
Quick Ratio	n/a
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-186.90

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	n/a
Return on Capital Employed (ROCE)	n/a
Weighted Average Cost of Capital (WACC)	11.31%
Revenue Per Employee	786
Profits Per Employee	-760,253
Employee Count	4
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	-389,871
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -54.89% in the last 52 weeks. The beta is 1.28, so NFL Biosciences's price volatility has been higher than the market average.

Beta (5Y)	1.28
52-Week Price Change	-54.89%
50-Day Moving Average	0.62
200-Day Moving Average	0.88
Relative Strength Index (RSI)	32.51
Average Volume (20 Days)	89,026

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, NFL Biosciences had revenue of EUR 3,145 and -3.04 million in losses.

Revenue	3,145
Gross Profit	-2.52M
Operating Income	-3.74M
Pretax Income	-3.43M
Net Income	-3.04M
EBITDA	n/a
EBIT	-3.74M
Earnings Per Share (EPS)	n/a

Full Income Statement

Balance Sheet

Cash & Cash Equivalents	n/a
Total Debt	n/a
Net Cash	n/a
Net Cash Per Share	n/a
Equity (Book Value)	n/a
Book Value Per Share	n/a
Working Capital	n/a

Full Balance Sheet

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Depreciation & Amortization	n/a
Net Borrowing	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	-118,911.41%
Pretax Margin	-109,090.11%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

NFL Biosciences does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
FCF Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-60.45%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a
Graham Formula Value	n/a
Graham Formula Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1